News and Announcements
Coretrack (ASX:CKK) Latest Announcements
- Published August 08, 2014 9:39AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16/07/2014 – Coretrack Raises $2 Million – PDF
07/08/2014 – Coretrack Wins Case Against Strange Investments (WA) Pty Ltd – PDF
Coretrack (ASX:CKK) has developed disruptive, Game Changer technology for ceramic proppants made primarily from CCP’s (aka flyash), the abundant by-product of coal-fired power plants. The major commodity used in any oil and gas well is proppants, i.e. a $10 million well requires ± $2 million of proppants.
Ecopropp’s high strength, lightweight ceramic proppants are engineered for shale wells deeper than 2 kilometres, therefore do not threaten water aquifers that are often located less than 300 metres deep.
Expansion is planned in the rapidly expanding US shale plays, where many wells use lightweight ceramic proppants due to ever increasing well depth. The majority of ceramic proppants currently come from China or Georgia, which increases our competitive advantage and profit potential.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
